Type 1 diabetes mellitus with diabetic nephropathy
ICD-10 E10.21 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with diabetic nephropathy.
E10.21 refers to Type 1 diabetes mellitus with diabetic nephropathy, a serious complication of diabetes characterized by kidney damage due to prolonged high blood sugar levels. In Type 1 diabetes, the body does not produce insulin, leading to elevated glucose levels that can damage blood vessels in the kidneys over time. Diabetic nephropathy is marked by the presence of protein in the urine (albuminuria), decreased kidney function, and can progress to end-stage renal disease if not managed effectively. Patients with this condition often require close monitoring of their HbA1c levels, which should ideally be maintained below 7% to minimize complications. Insulin management is crucial, as patients typically require exogenous insulin to control their blood glucose levels. Regular screening for nephropathy is recommended, including urine tests for microalbumin and serum creatinine levels to assess kidney function. Early detection and intervention can slow the progression of nephropathy and improve patient outcomes.
Detailed records of blood glucose levels, HbA1c results, and insulin regimen.
Management of Type 1 diabetes with complications, including nephropathy.
Ensure clear documentation of diabetes management plans and nephropathy assessments.
Comprehensive renal function tests, urine analysis, and treatment plans.
Patients presenting with renal impairment secondary to diabetes.
Document the stage of nephropathy and any interventions performed.
Used to monitor glycemic control in patients with diabetes.
Document the date of the test and results.
Endocrinologists should ensure regular A1c testing is part of the management plan.
Coding E10.21 accurately reflects the patient's condition, ensuring appropriate management and reimbursement for the complexities associated with Type 1 diabetes and its complications.